BV Cyclotron VU produces a wide range of radiopharmaceuticals and research products for the nuclear medicine community. These products range from PET tracers to on-demand, tailor-made products for research or clinical use.
Our portfolio contains eight products, with a current production output of 35,000 patient doses per year. With three cyclotrons and several GMP hot labs, we are one of the best-equipped centers for the production of radiopharmaceuticals in the Benelux region, and the first commercial manufacturer of GMP-compliant zirconium-89 and iodine-124 in the world. Our expert team ensures operational safety of the cyclotrons and the highest possible product quality.
By 2017 we will have further enhanced our position as a European leader in nuclear medicine research and product development by establishing a new cyclotron facility and expanding our production. This facility is planned as part of the VUmc Imaging Center.
- Zirconium-89 for radiolabeling
- Iodine-124 for radiolabeling
- Sodium Iodide 124I for injection
- 18F-Florbetaben (Neuraceq)
- KryptoScanTM: 81Rb/81mKr Generator
- Type A Transport Container: Lead or Tungsten
Due to radioactive decay times, which can range from several hours to a few days, timing is everything. We have a tight production schedule, which is planned in November for the whole following calendar year.
See here the most recent production schedule for all our products.
BV Cyclotron VU is a global health science company that produces radiopharmaceuticals and radiochemicals for medical diagnostics and research. Located at the campus of VU University Medical Center in Amsterdam, BV Cyclotron VU produces GMP-compliant medical isotopes in state-of-the-art manufacturing facilities. They are used daily by pharmaceutical and biotechnological companies, medical device manufacturers, hospitals, clinics, and research laboratories.
Order our products directly from one of our distribution partners.